Accurate peptide dosage calculation is one of the most critical skills for any researcher working with peptide compounds. A miscalculation during reconstitution can mean the difference between a successful experiment and wasted resources — or worse, confounded data that takes weeks to untangle. This comprehensive guide walks you through every aspect of peptide dosage math, from basic reconstitution calculations to advanced concentration formulas, syringe unit conversions, and practical dosing examples for the most commonly researched peptides.
Whether you’re reconstituting your first vial of BPC-157 or calibrating precise microgram doses of semaglutide for a dose-response study, mastering these calculations ensures reproducible, reliable results every time.
The Fundamentals: Reconstitution Math
Reconstitution is the process of dissolving lyophilized (freeze-dried) peptide powder into a liquid solution. The amount of diluent you add determines the concentration of your solution, which in turn determines how much liquid you need to draw for each dose.
The Core Formula
The fundamental reconstitution equation is elegantly simple:
Concentration (mcg/mL) = Total Peptide Amount (mcg) ÷ Volume of Diluent (mL)
For example, if you have a 5mg (5,000mcg) vial of BPC-157 and add 2mL of bacteriostatic water:
- 5,000mcg ÷ 2mL = 2,500mcg per mL
- This means every 1mL of solution contains 2,500mcg of peptide
- Every 0.1mL (10 units on an insulin syringe) contains 250mcg
Choosing Your Diluent Volume
The volume of diluent you add is flexible, but your choice affects practical usability:
Less diluent (e.g., 1mL):
- Creates a more concentrated solution
- Smaller injection volumes needed per dose
- Higher risk of measurement error (small volume differences = large dose differences)
- Best for: High-dose protocols where you want minimal injection volume
More diluent (e.g., 3-5mL):
- Creates a more dilute solution
- Larger injection volumes per dose, but more precise measurement
- Better accuracy for low-dose protocols
- Best for: Dose-response studies requiring precise microgram control
The sweet spot for most research applications is 2mL of bacteriostatic water per 5mg vial, providing a balance of concentration and measurability.
Common Reconstitution Calculations
Here are ready-reference calculations for the most common vial sizes:
5mg vial + 2mL bacteriostatic water:
- Concentration: 2,500mcg/mL (2.5mg/mL)
- Per 10 units (0.1mL): 250mcg
- Per 5 units (0.05mL): 125mcg
- Per 1 unit (0.01mL): 25mcg
5mg vial + 1mL bacteriostatic water:
- Concentration: 5,000mcg/mL (5mg/mL)
- Per 10 units: 500mcg
- Per 5 units: 250mcg
- Per 1 unit: 50mcg
10mg vial + 2mL bacteriostatic water:
- Concentration: 5,000mcg/mL (5mg/mL)
- Per 10 units: 500mcg
- Per 5 units: 250mcg
- Per 1 unit: 50mcg
2mg vial + 2mL bacteriostatic water:
- Concentration: 1,000mcg/mL (1mg/mL)
- Per 10 units: 100mcg
- Per 5 units: 50mcg
- Per 1 unit: 10mcg
Understanding Insulin Syringes & Unit Measurements
Insulin syringes are the standard measurement tool for peptide research due to their fine graduations and precise volume control. Understanding how syringe units translate to volume is essential for accurate dosing.
Syringe Types and Capacities
The most common insulin syringes used in peptide research:
U-100 Insulin Syringes (most common):
- 100 units = 1mL — This is the critical conversion factor
- Available in 0.3mL (30 unit), 0.5mL (50 unit), and 1mL (100 unit) sizes
- Graduation marks typically every 1 or 2 units
- Needle gauges: 29G, 30G, or 31G (higher number = thinner needle)
For peptide research, the 0.5mL (50 unit) syringe is often ideal — it provides sufficient capacity for most doses while maintaining readable graduation marks for precise measurement.
Converting Between Units, mL, and mcg
The conversion chain works as follows:
- Determine your concentration (from reconstitution math above)
- Convert units to mL: Divide syringe units by 100 (for U-100 syringes)
- Calculate mcg per draw: Multiply mL by concentration
Example: You have a 5mg vial reconstituted with 2mL bac water (concentration: 2,500mcg/mL). You want to draw 250mcg.
- 250mcg ÷ 2,500mcg/mL = 0.1mL
- 0.1mL × 100 units/mL = 10 units on the syringe
Reverse calculation: You drew 15 units from the same vial. How many mcg is that?
- 15 units ÷ 100 = 0.15mL
- 0.15mL × 2,500mcg/mL = 375mcg
Advanced Calculations: IU Conversions
Some peptides, particularly growth hormone and growth hormone secretagogues, are sometimes referenced in International Units (IU) rather than micrograms. Understanding the conversion between these units is important for interpreting research literature.
Growth Hormone IU/mg Conversion
For recombinant human growth hormone (rhGH):
- 1mg ? 3 IU (this is the standard conversion for modern recombinant GH)
- Older somatropin preparations used different potencies, so always verify with the specific product
Growth Hormone Secretagogue Considerations
Peptides like ipamorelin and CJC-1295 are dosed in micrograms, not IU. However, their effect on GH release is often measured in IU of GH secreted. This is an important distinction — the peptide dose (in mcg) is not directly convertible to IU of GH output, as the response varies based on individual factors, timing, and combination protocols. See our ipamorelin + CJC-1295 stack guide for research protocol details.
BPC-157: mcg Dosing
BPC-157 is exclusively dosed in micrograms. Research protocols in the literature typically reference doses in the range of 1-10mcg per kilogram of body weight in animal models. This does NOT directly translate to research protocols in other contexts — the appropriate dose depends entirely on the specific research design and model system.
Practical Dosing Examples by Peptide
Below are reconstitution and dosing calculation examples for commonly researched peptides. These examples demonstrate the math — they are not therapeutic recommendations.
Semaglutide (5mg vial)
Reconstitution: 5mg + 2mL bacteriostatic water = 2,500mcg/mL
- Research reference dose of 250mcg = 10 units (0.1mL)
- Research reference dose of 500mcg = 20 units (0.2mL)
- Research reference dose of 1,000mcg (1mg) = 40 units (0.4mL)
- Vial yields: 20 doses at 250mcg, or 10 doses at 500mcg
For research context on semaglutide dosing in clinical trials, see our semaglutide weight loss results analysis covering the STEP trial dose escalation protocols.
Tirzepatide (5mg vial)
Reconstitution: 5mg + 2mL bacteriostatic water = 2,500mcg/mL
- Research reference dose of 2,500mcg (2.5mg) = 100 units (1mL) — requires full syringe
- Research reference dose of 5,000mcg (5mg) = entire vial
- For lower research doses: 500mcg = 20 units, 1,000mcg = 40 units
BPC-157 (5mg vial)
Reconstitution: 5mg + 2mL bacteriostatic water = 2,500mcg/mL
- Research reference dose of 250mcg = 10 units
- Research reference dose of 500mcg = 20 units
- Research reference dose of 750mcg = 30 units
- Vial yields: 20 doses at 250mcg, or 10 doses at 500mcg
Ipamorelin (5mg vial)
Reconstitution: 5mg + 2mL bacteriostatic water = 2,500mcg/mL
- Research reference dose of 100mcg = 4 units
- Research reference dose of 200mcg = 8 units
- Research reference dose of 300mcg = 12 units
- Vial yields: 50 doses at 100mcg, or 25 doses at 200mcg
MOTS-C (5mg vial)
Reconstitution: 5mg + 2mL bacteriostatic water = 2,500mcg/mL
- Research reference dose of 5,000mcg (5mg) = entire vial (some protocols use weekly)
- Research reference dose of 10,000mcg (10mg) = two vials
- For lower research doses: 2,500mcg = 100 units (1mL)
Creating a Quick-Reference Dosing Chart
For ongoing research programs, creating a standardized dosing chart saves time and reduces calculation errors. Here’s how to build one:
Step 1: Standardize Your Reconstitution Volume
Pick a consistent diluent volume across all peptides (e.g., 2mL for all 5mg vials). This simplifies calculations and reduces the chance of mixing up concentrations between different peptides.
Step 2: Calculate Your Standard Concentrations
Create a reference table:
- 5mg vial + 2mL = 2,500mcg/mL ? 250mcg per 10 units
- 10mg vial + 2mL = 5,000mcg/mL ? 500mcg per 10 units
- 2mg vial + 2mL = 1,000mcg/mL ? 100mcg per 10 units
Step 3: Map Doses to Syringe Units
For each peptide in your research program, create a line showing the exact syringe units needed for each target dose at your standard concentration. Post this chart in your research space for quick reference.
Step 4: Include Safety Checks
Add maximum volume alerts (e.g., “if your calculated draw exceeds 50 units, double-check the calculation”) and color-code different peptides to prevent cross-contamination errors.
Common Calculation Mistakes & How to Avoid Them
Even experienced researchers make dosing errors. Here are the most common mistakes and how to prevent them:
Mistake #1: Confusing mg and mcg
This is the most dangerous calculation error. 1mg = 1,000mcg. A 10x error in either direction can dramatically affect your research. Always double-check your unit conversions and standardize on one unit (mcg is recommended for peptide work).
Mistake #2: Forgetting to Account for Vial Overfill
Some manufacturers slightly overfill vials (e.g., a “5mg” vial might contain 5.2mg). For most research purposes this variation is negligible, but for precise dose-response studies, verify the actual content from the COA.
Mistake #3: Not Accounting for Dead Volume
Insulin syringes and vials have “dead volume” — small amounts of liquid that cannot be drawn out. A standard insulin syringe has approximately 0.005-0.01mL of dead volume. For expensive peptides, using a “dead volume” syringe can recover this lost product.
Mistake #4: Drawing Air Bubbles
Air bubbles in the syringe displace liquid, leading to under-dosing. Always:
- Draw past your target volume
- Tap the syringe barrel to float bubbles to the top
- Push the plunger to expel air and excess solution back to the exact target
Mistake #5: Using the Wrong Syringe Type
U-40 and U-100 syringes have different unit-to-volume conversions. Using a U-40 syringe with U-100 calculations results in a 2.5x dosing error. Always verify you’re using U-100 insulin syringes for standard peptide calculations. For more common errors, see our peptide reconstitution mistakes guide.
Multi-Peptide Research: Stacking Calculations
When researching multiple peptides simultaneously (stacking), additional calculations are needed:
Combining in the Same Syringe
Some researchers combine compatible peptides in a single syringe to reduce injection frequency. When doing so:
- Calculate each peptide’s volume independently
- Verify total combined volume doesn’t exceed syringe capacity
- Draw the peptide with the smaller volume first (reduces waste in dead volume)
- Confirm chemical compatibility — not all peptides can be safely mixed
Example: Ipamorelin + CJC-1295 Stack
Both reconstituted at 2,500mcg/mL (5mg in 2mL):
- Ipamorelin 200mcg = 8 units from ipamorelin vial
- CJC-1295 100mcg = 4 units from CJC-1295 vial
- Total draw: 12 units (0.12mL combined)
For detailed stacking protocols, see our growth hormone peptide stacks guide.
Frequently Asked Questions
How many units of insulin syringe equals 1mL?
On a standard U-100 insulin syringe, 100 units equals 1mL. This means 50 units = 0.5mL, 10 units = 0.1mL, and 1 unit = 0.01mL. This conversion is essential for all peptide dosage calculations.
How much bacteriostatic water should I add to a 5mg peptide vial?
The most common reconstitution volume for a 5mg vial is 2mL of bacteriostatic water, yielding a concentration of 2,500mcg/mL (250mcg per 10 units). However, you can use anywhere from 1mL to 5mL depending on your dosing requirements and desired precision.
What is the difference between bacteriostatic water and sterile water for reconstitution?
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, allowing the reconstituted peptide to remain stable for 3-4 weeks when refrigerated. Sterile water has no preservative and should be used within 48-72 hours. For multi-use vials, bacteriostatic water is strongly preferred.
How do I convert mcg to mg for peptide dosing?
Divide micrograms by 1,000 to get milligrams: 1,000mcg = 1mg. For example, 250mcg = 0.25mg, 500mcg = 0.5mg, and 2,500mcg = 2.5mg. Always double-check this conversion as errors here cause the most significant dosing mistakes.
Can I use the same syringe for different peptides?
No. Always use a fresh, sterile syringe for each peptide and each draw. Cross-contamination between vials can introduce bacteria and compromise both peptide integrity and research accuracy. Insulin syringes are inexpensive — never reuse them.
How do I know if my peptide has degraded after reconstitution?
Signs of degradation include: cloudiness or particulate matter in the solution (should be crystal clear), color changes, unusual odor, or inconsistent research results compared to previous batches. If you observe any of these signs, discard the vial and reconstitute a fresh one.
What if I accidentally add too much or too little bacteriostatic water?
If you add too much diluent, your concentration will be lower than intended — simply recalculate using the actual volume added. If you add too little, you can add more to reach your target volume. The key is to know the exact final volume so you can accurately calculate concentration. Never guess.
Peptide-Specific Dosing Reference Tables
Different peptides require different concentrations and dosing volumes depending on the typical research doses used in published literature. The following tables provide quick references for the most commonly studied research peptides available from Proxiva Labs.
Semaglutide Dosing Reference
Semaglutide research typically follows a dose-escalation protocol, starting at lower doses and increasing over time. Common research doses range from 0.25mg to 2.4mg per week. With semaglutide supplied as a lyophilized powder, reconstitution calculations are critical for achieving accurate weekly doses.
| Vial Size | Diluent Added | Concentration | 0.25mg Dose | 0.5mg Dose | 1.0mg Dose | 2.4mg Dose |
|---|---|---|---|---|---|---|
| 3mg | 1.5mL | 2mg/mL | 12.5 units | 25 units | 50 units | N/A* |
| 5mg | 2mL | 2.5mg/mL | 10 units | 20 units | 40 units | 96 units |
| 5mg | 1mL | 5mg/mL | 5 units | 10 units | 20 units | 48 units |
| 10mg | 2mL | 5mg/mL | 5 units | 10 units | 20 units | 48 units |
*Dose exceeds available amount in this vial configuration. Use a larger vial or more concentrated solution.
For semaglutide research, the typical escalation follows: 0.25mg weekly for 4 weeks, then 0.5mg for 4 weeks, then 1.0mg for maintenance. Higher-dose research protocols extend to 1.7mg and 2.4mg weekly as studied in the STEP clinical trial program. For more on semaglutide research outcomes, see our guide on semaglutide weight loss results.
BPC-157 Dosing Reference
BPC-157 is typically dosed in the microgram range, with research protocols commonly using 200-500mcg per administration. Due to the smaller doses involved, reconstitution volume selection significantly impacts measurement precision.
| Vial Size | Diluent | Concentration | 200mcg Dose | 250mcg Dose | 500mcg Dose |
|---|---|---|---|---|---|
| 5mg | 2mL | 2,500mcg/mL | 8 units | 10 units | 20 units |
| 5mg | 1mL | 5,000mcg/mL | 4 units | 5 units | 10 units |
| 10mg | 2mL | 5,000mcg/mL | 4 units | 5 units | 10 units |
For BPC-157 research protocols using twice-daily administration at 250mcg each (500mcg total daily), a 5mg vial reconstituted with 2mL provides exactly 10 days of research material. This makes inventory planning straightforward — one vial per 10 days at this protocol.
Ipamorelin and CJC-1295 Dosing Reference
Growth hormone secretagogue research frequently employs the ipamorelin and CJC-1295 (no DAC) stack. Typical research doses range from 100-300mcg for each peptide, administered 1-3 times daily.
| Peptide | Vial + Diluent | Concentration | 100mcg | 200mcg | 300mcg |
|---|---|---|---|---|---|
| Ipamorelin 5mg | 5mg + 2mL | 2,500mcg/mL | 4 units | 8 units | 12 units |
| CJC-1295 2mg | 2mg + 2mL | 1,000mcg/mL | 10 units | 20 units | 30 units |
| CJC-1295 5mg | 5mg + 2mL | 2,500mcg/mL | 4 units | 8 units | 12 units |
Advanced Concentration Concepts
Beyond basic reconstitution math, researchers working with multiple peptides or complex protocols need to understand several advanced concentration concepts that affect experimental accuracy.
Serial Dilutions for Ultra-Low Doses
Some research protocols require very low peptide doses — in the low microgram or even nanogram range — that cannot be accurately measured from a standard reconstitution. In these cases, serial dilution provides the solution.
A serial dilution involves creating a stock solution at a known concentration, then using a measured aliquot of that stock to create a second, more dilute solution. For example:
- Step 1: Reconstitute a 5mg vial with 2mL bacteriostatic water (concentration: 2,500mcg/mL)
- Step 2: Draw 0.1mL (10 units) from the vial — this contains 250mcg
- Step 3: Add this to a new sterile vial containing 0.9mL of bacteriostatic water
- Result: 250mcg in 1mL total = 250mcg/mL (a 10x dilution)
- Step 4: From this dilute solution, 10 units now contains 25mcg instead of 250mcg
This technique is standard practice in dose-response studies where researchers need to explore a wide range of concentrations. The key is meticulous labeling and documentation of each dilution step. Serial dilution errors compound — a 10% measurement error at each step becomes a 27% error after three steps.
Converting Between Units: mcg, mg, IU, and nmol
Research literature reports peptide doses in various units, which can create confusion when translating protocols. Here are the key conversions:
Mass conversions:
- 1mg = 1,000mcg (micrograms)
- 1mcg = 1,000ng (nanograms)
- 1g = 1,000mg
International Units (IU): IU is a pharmacological measure based on biological activity, not mass. The IU-to-mcg conversion varies by peptide:
- Human Growth Hormone (hGH): 1mg = 3 IU (approximately)
- Insulin: 1mg = approximately 26-30 IU (varies by formulation)
- EPO: 1mg = approximately 100,000 IU
Molar conversions (nmol): Some research papers report doses in nanomoles (nmol) or picomoles (pmol). Converting requires the peptide’s molecular weight:
Amount (nmol) = Amount (mcg) ÷ Molecular Weight (kDa)
For BPC-157 (molecular weight ~1,419 Da or 1.419 kDa):
- 250mcg = 250 ÷ 1.419 = 176.2 nmol
- 500mcg = 500 ÷ 1.419 = 352.4 nmol
For semaglutide (molecular weight ~4,114 Da or 4.114 kDa):
- 1,000mcg (1mg) = 1,000 ÷ 4.114 = 243.1 nmol
- 2,400mcg (2.4mg) = 2,400 ÷ 4.114 = 583.4 nmol
Dead Volume and Overfill Considerations
Every syringe has a dead volume — the small amount of solution that remains in the hub and needle after the plunger is fully depressed. For standard insulin syringes, dead volume is typically 0.02-0.07mL (2-7 units). While this seems negligible, it represents a non-trivial percentage of small doses.
For a 250mcg dose drawn from a 2,500mcg/mL solution (10 units), a dead volume of 5 units means you are wasting approximately 125mcg of peptide with each injection — nearly 50% of the dose. Over a 30-day research protocol, this wasted peptide adds up to 3,750mcg (3.75mg) lost to dead volume alone.
Strategies to minimize dead volume loss:
- Use low-dead-space syringes (specifically designed with reduced hub volume)
- Use the air-lock technique: draw a small air bubble after drawing the peptide, which pushes solution out of the dead space during injection
- Account for dead volume in your total supply calculations when planning research duration
- For expensive peptides, factor dead volume loss into budget projections
Step-by-Step Reconstitution Walkthrough
Even experienced researchers benefit from a standardized reconstitution protocol. Consistency in technique minimizes variability between vials and experiments. The following protocol applies to all lyophilized peptides.
Materials required:
- Lyophilized peptide vial
- Bacteriostatic water (0.9% benzyl alcohol preserved)
- Insulin syringe (1mL, 100 units, 29-31 gauge)
- Alcohol swabs
- Clean work surface
Protocol:
- Calculate your target concentration before opening anything. Determine how much diluent to add based on your dosing needs. Write this down.
- Clean the vial stoppers of both the peptide vial and the bacteriostatic water vial with alcohol swabs. Allow 10-15 seconds of contact time before proceeding.
- Draw the calculated volume of bacteriostatic water into the syringe. Remove air bubbles by tapping the syringe and gently pushing the plunger until only liquid remains.
- Inject diluent slowly along the inside wall of the peptide vial, angling the needle so the stream runs down the glass. Never spray directly onto the lyophilized cake — the force can damage peptide structure and cause foaming.
- Swirl gently to dissolve. Tilt the vial at a 45-degree angle and roll it between your fingers. The peptide should dissolve within 30-60 seconds for most compounds. Some peptides (particularly larger ones like CJC-1295 with DAC) may take several minutes.
- Never shake a peptide vial. Vigorous shaking introduces air bubbles, creates foam, and can denature the peptide through mechanical stress. This is one of the most common reconstitution mistakes — see our full guide on reconstitution mistakes to avoid.
- Inspect the solution. It should be clear and colorless. Cloudiness, particulates, or persistent foam may indicate degradation, contamination, or improper reconstitution. Do not use cloudy solutions.
- Label the vial immediately with: peptide name, concentration (mcg/mL), date of reconstitution, and expiration (typically 28-30 days for bacteriostatic water reconstitution when refrigerated).
- Store at 2-8 degrees C (standard refrigerator temperature). Never freeze reconstituted peptide solutions — ice crystal formation can damage peptide structure irreversibly.
Common Dosage Calculation Mistakes
Years of working with research peptides have revealed consistent patterns of calculation errors. Understanding these common pitfalls prevents wasted peptides and compromised research data.
Mistake 1: Confusing mg and mcg
This is by far the most dangerous dosage error. One milligram equals one thousand micrograms. Accidentally using mg where mcg was intended results in a 1,000-fold overdose. Always double-check your units before drawing any solution. Many experienced researchers use the convention of writing “mcg” in full rather than using the abbreviation to avoid ambiguity with handwritten notes.
Mistake 2: Forgetting the Peptide Is Already in Solution
After reconstitution, some researchers add additional diluent to “top off” the vial, not realizing this changes the concentration. If you reconstituted 5mg with 2mL (2,500mcg/mL) and later add another 0.5mL of bacteriostatic water, your concentration drops to 2,000mcg/mL. All subsequent dose calculations based on the original concentration will be 20% too high.
Mistake 3: Not Accounting for Insulin Syringe Markings
Standard U-100 insulin syringes mark 100 units per 1mL. Each “unit” on the syringe equals 0.01mL. This is NOT the same as an IU (International Unit) of any peptide. The syringe “units” are purely volumetric — they tell you how many hundredths of a milliliter you are drawing, nothing about the peptide dose. The actual peptide dose depends entirely on your reconstitution concentration.
Mistake 4: Using Different Syringes Interchangeably
U-100 and U-40 insulin syringes exist, and they are NOT interchangeable. A U-40 syringe draws 2.5 times more volume per marked “unit” than a U-100 syringe. Using a U-40 syringe with calculations designed for U-100 results in a 2.5x overdose. Always verify your syringe type before calculating doses. For peptide research, U-100 syringes are standard.
Mistake 5: Rounding Errors in Multi-Step Calculations
When performing multi-step calculations, carry full decimal precision through intermediate steps and only round the final answer. Rounding intermediate values introduces cumulative error. For a calculation that passes through three steps, premature rounding at each step can result in final values that are off by 5-10% or more from the correct answer.
Dosage Tracking and Documentation
Accurate dosage documentation is as important as accurate calculation. Research integrity depends on knowing exactly what concentration was administered, when, and by what route. A systematic approach to record-keeping prevents confusion and supports reproducibility.
Essential records for each reconstitution event:
- Peptide name and lot number
- Vial size (total peptide mass)
- Volume of diluent added
- Resulting concentration (mcg/mL)
- Date and time of reconstitution
- Storage conditions
- Expiration date (typically 28 days post-reconstitution for BAC water)
For each administration:
- Date and time
- Volume drawn (in syringe units and mL)
- Calculated dose (in mcg or mg)
- Route of administration
- Injection site (for rotation tracking)
- Any observations (solution clarity, unusual resistance, etc.)
Maintaining a standardized lab notebook or digital log with these fields creates an auditable record that supports publication-quality research documentation. It also makes it straightforward to identify and trace back any anomalous results to potential dosing variables.
Tirzepatide Dosing Reference
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied in the SURPASS and SURMOUNT clinical trial programs. Research doses range from 2.5mg to 15mg per week, following a structured escalation schedule that increases every 4 weeks.
| Vial Size | Diluent | Concentration | 2.5mg Dose | 5mg Dose | 10mg Dose | 15mg Dose |
|---|---|---|---|---|---|---|
| 5mg | 1mL | 5mg/mL | 50 units | Full vial | N/A | N/A |
| 10mg | 1mL | 10mg/mL | 25 units | 50 units | Full vial | N/A |
| 15mg | 1.5mL | 10mg/mL | 25 units | 50 units | 100 units | Full vial |
| 30mg | 2mL | 15mg/mL | 16.7 units | 33 units | 67 units | 100 units |
The standard tirzepatide escalation in clinical research is: 2.5mg weekly for weeks 1-4, 5mg for weeks 5-8, 7.5mg for weeks 9-12, 10mg for weeks 13-16, 12.5mg for weeks 17-20, and 15mg for weeks 21+. For a detailed comparison of tirzepatide and semaglutide dosing, see our tirzepatide vs semaglutide analysis.
Retatrutide Dosing Reference
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical data used doses ranging from 1mg to 12mg weekly with dose escalation.
| Vial Size | Diluent | Concentration | 1mg Dose | 4mg Dose | 8mg Dose | 12mg Dose |
|---|---|---|---|---|---|---|
| 5mg | 1mL | 5mg/mL | 20 units | 80 units | N/A | N/A |
| 10mg | 1mL | 10mg/mL | 10 units | 40 units | 80 units | Full vial + 20 units from 2nd |
Temperature and Storage Effects on Concentration
Temperature fluctuations can subtly affect peptide solution concentration and stability, though these effects are often overlooked in dosage calculations.
Thermal expansion of water: Bacteriostatic water, like all aqueous solutions, expands when heated and contracts when cooled. The volume of 2mL at 4 degrees C (refrigerator) is measurably different from 2mL at 25 degrees C (room temperature). While this difference is typically less than 1%, researchers conducting highly precise dose-response studies should be aware of it. Reconstitute at room temperature and store at refrigerator temperature for consistency, and always draw doses at the same temperature condition.
Peptide degradation over time: Even when properly stored, reconstituted peptides undergo gradual degradation. BPC-157 in bacteriostatic water at 4 degrees C maintains stability for approximately 28 days, but potency may decline by 5-15% over that period depending on the specific peptide and storage conditions. This means a nominal 250mcg dose drawn on day 28 might deliver closer to 215-240mcg of active peptide. For research where this matters, reconstituting smaller amounts more frequently improves dosing accuracy.
Freeze-thaw damage: Freezing reconstituted peptide solutions causes ice crystal formation that can mechanically damage peptide structure, leading to aggregation and loss of bioactivity. The concentration of intact, bioactive peptide decreases with each freeze-thaw cycle. If you must store reconstituted solution long-term, aliquot it into single-use portions in separate vials before freezing, so each aliquot only undergoes one freeze-thaw cycle. However, for most research purposes, simply reconstituting a fresh vial every 2-4 weeks is preferable.
Quality Control: Verifying Your Calculations
Before proceeding with any peptide research protocol, implementing a verification step catches calculation errors that could compromise your entire study.
The reverse-calculation check: After calculating your dose volume, work backward to verify. If you calculated that 8 units delivers 200mcg from a 2,500mcg/mL solution, check: 8 units = 0.08mL; 0.08mL x 2,500mcg/mL = 200mcg. The forward and reverse calculations should match exactly.
The total-vial check: Calculate how many total doses the vial should provide at your protocol dose. If a 5mg vial reconstituted with 2mL provides 2,500mcg/mL and your dose is 250mcg, the vial should provide 5,000mcg / 250mcg = 20 doses (minus dead volume losses). If your protocol is 2 doses per day, the vial should last approximately 10 days. If this duration seems wrong relative to your experience or expectations, re-examine the calculation.
Cross-reference published protocols: When replicating a published research protocol, verify that your calculated volumes are consistent with the volumes described in the methods section. If a paper states they administered 0.1mL of a solution and your calculations suggest 0.5mL for the same dose, something is off — likely a reconstitution concentration difference or a unit conversion error.
Accurate calculations are the foundation of meaningful peptide research. Combined with high-purity research materials from Proxiva Labs and proper technique, precise dosing ensures that your experimental results reflect the true pharmacological properties of the compounds under study. View our comprehensive third-party test results to verify the purity of your research materials.
Multi-Peptide Protocol Calculations
Advanced research protocols frequently involve administering multiple peptides simultaneously or in sequence. Calculating doses for multi-peptide protocols requires careful organization to avoid cross-contamination and dosing errors.
Key principles for multi-peptide protocols:
- Use separate syringes for each peptide. Never draw multiple peptides into the same syringe unless the protocol specifically calls for co-administration and compatibility has been verified.
- Label everything. When working with multiple vials simultaneously, misidentification is the most common source of error. Color-coded labels or clearly written identifiers prevent this.
- Calculate total daily volume. If your protocol involves three peptides each requiring 0.2mL per dose, the total daily injection volume is 0.6mL (or more with multiple daily doses). Excessive daily injection volume can affect research subjects and should be considered in protocol design.
- Plan supply logistics. Calculate how many vials of each peptide are needed for the entire protocol duration, including waste from dead volume. Order sufficient supply before beginning the research to avoid mid-protocol interruptions.
All peptides referenced in this guide are available from Proxiva Labs with verified purity testing. For additional guidance on handling and storage, see our comprehensive guide to how peptides work.
Related Articles
- 10 Peptide Reconstitution Mistakes Researchers Make
- Ipamorelin & CJC-1295 Stack: Complete Research Protocol
- Growth Hormone Peptide Stacks: Research Combinations
- How to Choose a Peptide Supplier: Quality Checklist
Research Disclaimer: This article is intended for educational and informational purposes only. All peptides referenced are for research use only and are not intended for human consumption. The dosage calculations and examples provided are for research reference and do not constitute medical advice or therapeutic dosing recommendations. Proxiva Labs does not provide medical advice. Always conduct research in accordance with applicable regulations and institutional guidelines.